State Health Investment Project: Impact Evaluation Endline Survey, 2017
Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
Producer(s)
Eeshani Kandpal (World Bank)
Created on
Dec 05, 2022
Last modified
Aug 28, 2024
Page views
140440
Downloads
507
- Data files
- cardio_drugs_noid.dta
- Catchment_Area_noid.dta
- decr_services_noid.dta
- diagnostic_kits_noid.dta
- FP_drugs_noid.dta
- general_drugs_noid.dta
-
Health Facility
(HF1)_noid.dta - HF1_Sect08_noid.dta
- HF1_sect10A_noid.dta
- HF1_Sect10B_noid.dta
- incr_services_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- malaria_drugs_noid.dta
- obstetric_care_noid.dta
- Q1611_positions_noid.dta
- services_noid.dta
- TB_drugs_noid.dta
- vaccines_noid.dta
- anc_patients_noid.dta
- HF3_HCP_Info_noid.dta
- HF4_HCP_Info_noid.dta
- HF4_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient DIRECT
OBSERVATION
(HF3_HF4)_noid.dta - HF5_ASSETS_noid.dta
- HF5_LIVESTOCK_noid.dta
- HF5_patients_noid.dta
- HF6_ASSETS_noid.dta
- HF6_LIVESTOCK_noid.dta
- HF6_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient EXIT
INTERVIEW
(HF5_HF6)_noid.dta -
Health Care
Provider
Interviews
(HF7)_noid.dta - HF7_Q202_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- staff_roster_noid.dta
- Durable_Goods_noid.dta
- hhroster_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
NSHIP IE
Midline
Household Women
Questionnaire_noid.dta - Q16_13_noid.dta
- S5C_Assets_noid.dta
- S9_Vaccines_noid.dta
- Sec_05B_noid.dta
- Sec_06A_noid.dta
- Sec_06B_noid.dta
- Sec_06C_noid.dta
- Sec_07_noid.dta
(Q11.20e) What is the strength of [DRUGS] that is stocked? (Q1120e1)
Data file: TB_drugs_noid.dta
Overview
Valid:
998
Invalid:
-
Minimum:
0
Maximum:
1000
Type:
Discrete
Decimal:
2
Start:
3
End:
9
Width:
7
Range:
0 - 1000
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 46 |
4.6%
|
|
| 1 | 22 |
2.2%
|
|
| 1.9 | 1 |
0.1%
|
|
| 2 | 4 |
0.4%
|
|
| 3 | 7 |
0.7%
|
|
| 4 | 2 |
0.2%
|
|
| 5 | 16 |
1.6%
|
|
| 7 | 2 |
0.2%
|
|
| 10 | 3 |
0.3%
|
|
| 19 | 2 |
0.2%
|
|
| 20 | 5 |
0.5%
|
|
| 21 | 1 |
0.1%
|
|
| 25 | 12 |
1.2%
|
|
| 30 | 3 |
0.3%
|
|
| 40 | 2 |
0.2%
|
|
| 50 | 3 |
0.3%
|
|
| 60 | 4 |
0.4%
|
|
| 75 | 144 |
14.4%
|
|
| 80 | 1 |
0.1%
|
|
| 100 | 25 |
2.5%
|
|
| 120 | 5 |
0.5%
|
|
| 125 | 12 |
1.2%
|
|
| 140 | 4 |
0.4%
|
|
| 150 | 193 |
19.3%
|
|
| 150.75 | 1 |
0.1%
|
|
| 175 | 8 |
0.8%
|
|
| 200 | 11 |
1.1%
|
|
| 225 | 2 |
0.2%
|
|
| 250 | 11 |
1.1%
|
|
| 270 | 2 |
0.2%
|
|
| 275 | 155 |
15.5%
|
|
| 280 | 1 |
0.1%
|
|
| 300 | 36 |
3.6%
|
|
| 370 | 3 |
0.3%
|
|
| 400 | 153 |
15.3%
|
|
| 425 | 1 |
0.1%
|
|
| 500 | 20 |
2%
|
|
| 600 | 4 |
0.4%
|
|
| 625 | 1 |
0.1%
|
|
| 650 | 2 |
0.2%
|
|
| 700 | 2 |
0.2%
|
|
| 750 | 2 |
0.2%
|
|
| 760 | 2 |
0.2%
|
|
| 800 | 5 |
0.5%
|
|
| 900 | 34 |
3.4%
|
|
| 925 | 3 |
0.3%
|
|
| 960 | 7 |
0.7%
|
|
| 1000 | 13 |
1.3%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.